The Strategy Committee consists of three directors, Mr Fei, Dr Gao Songjian and Dr Xiao Fei. Mr Fei has been appointed chairman of the Strategy Committee. The main responsibility of the Strategy Committee is to study and make recommendations on the long-term strategy and major investments of the Group.

The Company has established an Audit Committee and set out its terms of reference in writing in accordance with rule 3.21 of the Listing Rules and the Corporate Governance Code set out in Appendix 14 of the Listing Rules (the "Corporate Governance Code"). The Audit Committee consists of three members, namely, independent non-Executive Directors Dr Xiao Fei, Mr Chen Yi and Mr Jin Yiting. Mr Chen Yi, an independent non-executive director with appropriate professional qualifications, has been appointed as chairman of the Audit Committee. The main duties of the Audit Committee are to review and monitor the Group's financial reporting procedures and internal control systems, to monitor the audit procedures, to review and monitor the Group's existing and potential risks and to perform other duties and responsibilities as designated by the Board of Directors.

The company has been incorporated in accordance with Section 3.25 of the Listing Rules and the Code of Corporate Governance and has set out its terms of reference in writing. The Remuneration Committee consists of two independent non-executive directors, Mr Jin Yiting and Dr Xiao Fei, and one executive Director, Mr Chen Junhua. Mr Jin Yiting, an independent non-executive Director, has been appointed as chairman of the Remuneration Committee. The main responsibilities of the Remuneration Committee are to establish and review the remuneration policy and structure for directors and senior management and to make recommendations on employee benefits arrangements.

The Company has established a nomination Committee in accordance with the Code of Corporate Governance and has set out its terms of reference in writing. The nomination Committee consists of two independent non-executive directors (Dr Xiao Fei and Mr Chen Yi) and one executive Director (Mr Xia Guoping). Independent non-executive Director Dr Xiao Fei has been appointed as chairman of the nomination Committee. The primary function of the nominating Committee is to make recommendations to the Board on the appointment and removal of directors of the Company.

The company has established a risk management committee. The function of the Risk Management Committee is to monitor the extent to which we are exposed to sanctions risk and the extent to which we are implementing relevant internal control procedures. See "Operations - Operations in Countries subject to international sanctions" for more details. . The Risk Management Committee consists of three executive directors, Mr Fei, Mr Chen Yi and Mr Zheng Yuhong. Mr. Fei is the Chairman of the Risk Management Committee.